AbbVie Inc. (NYSE:ABBV) is listed among the 13 Best Roth IRA Stocks to Buy Now. Evercore ISI analyst cuts AbbVie’s price target, stating consensus for 2026 and 2027 looks beatable. Despite strong Q4 results, concerns arise over Rinvoq’s revenue shortfall impacting future growth drivers. Skyrizi and Rinvoq are expected to generate over $31 billion in 2026.

Read more at Yahoo Finance: Evercore ISI Cuts AbbVie Inc. (ABBV) PT, Says Consensus for 2026 and 2027 Still Looks Beatable